Market revenue in 2023 | USD 5,848.3 million |
Market revenue in 2030 | USD 9,266.3 million |
Growth rate | 6.8% (CAGR from 2023 to 2030) |
Largest segment | Diagnostic ent devices |
Fastest growing segment | Diagnostic ENT Devices |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diagnostic ENT Devices, Surgical ENT Devices, Hearing Aids, Hearing Implants, Nasal Splints |
Key market players worldwide | Ambu A/S ADR, Cochlear Ltd, Demant A/S, GN Store Nord A/S, Olympus Corp, RION Co Ltd, Smith & Nephew PLC, Sonova Holding AG, Stryker Corp, Karl Storz, Pentax Medical, Richard Wolf, Starkey, Omnicom Group Inc, NICO, Nemera |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ent devices market will help companies and investors design strategic landscapes.
Diagnostic ent devices was the largest segment with a revenue share of 68.7% in 2023. Horizon Databook has segmented the Asia Pacific ent devices market based on diagnostic ent devices, surgical ent devices, hearing aids, hearing implants, nasal splints covering the revenue growth of each sub-segment from 2018 to 2030.
The Asia Pacific region is majorly driven by China and Japan. Japan dominated the overall ENT devices market in Asia Pacific region. This can be attributed to large geriatric population. India is anticipated to be the fastest growing market during the forecast period in the Asia Pacific region.
Singapore, Thailand, Australia, and South Korea are some of the emerging countries in rest of the Asia Pacific region. Technological advancements, such as wireless, real-time monitoring, increase in healthcare spending in the Asia Pacific region, and support from regulatory bodies are anticipated to promote growth of the ENT devices market.
According to National Center for Biotechnology Information study, the overall prevalence of Chronic Rhinosinusitis (CRS) was 8.0% and ranged from 4.8% to 9.7% in seven cities. Chronic sinusitis affected approximately 107 million people in mainland China.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific ent devices market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific ent devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account